2011
DOI: 10.1186/1743-422x-8-306
|View full text |Cite
|
Sign up to set email alerts
|

Neutralizing antibody response in the patients with hand, foot and mouth disease to enterovirus 71 and its clinical implications

Abstract: Enterovirus 71 (EV71) has emerged as a significant pathogen causing large outbreaks in China for the past 3 years. Developing an EV71 vaccine is urgently needed to stop the spread of the disease; however, the adaptive immune response of humans to EV71 infection remains unclear. We examined the neutralizing antibody titers in HFMD patients and compared them to those of asymptomatic healthy children and young adults. We found that 80% of HFMD patients became positive for neutralizing antibodies against EV71 (GMT… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
45
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(50 citation statements)
references
References 29 publications
(34 reference statements)
5
45
0
Order By: Relevance
“…To date, that is not well understood. Our data also indicated that the serum titers of specific NAb-EV71 in patients with acute stage of EV71 infection were higher than those in HC (severe or mild cases versus HC, P < 0.0001), but no significant difference was observed between mild and severe patients groups (severe versus mild cases, P = 0.9693), which corresponded to previous studies [3]. Additionally, we found that enhanced frequency of circulating CXCR5 + CD4 + TFH, PD-1 high CXCR5 + CD4 + TFH, and ICOS high CXCR5 + CD4 + TFH cells was notably positively correlated with the titres of specific NAb-EV71 in patients with EV71 infection, and a significant association was not observed between the mild and severe patients, respectively.…”
Section: Discussionsupporting
confidence: 91%
“…To date, that is not well understood. Our data also indicated that the serum titers of specific NAb-EV71 in patients with acute stage of EV71 infection were higher than those in HC (severe or mild cases versus HC, P < 0.0001), but no significant difference was observed between mild and severe patients groups (severe versus mild cases, P = 0.9693), which corresponded to previous studies [3]. Additionally, we found that enhanced frequency of circulating CXCR5 + CD4 + TFH, PD-1 high CXCR5 + CD4 + TFH, and ICOS high CXCR5 + CD4 + TFH cells was notably positively correlated with the titres of specific NAb-EV71 in patients with EV71 infection, and a significant association was not observed between the mild and severe patients, respectively.…”
Section: Discussionsupporting
confidence: 91%
“…75 EV-A71 elicits humoral responses, but there is no correlation between neutralizing antibody levels and disease severity indicating that altered cellular responses such as an imbalance in Th1/Th2 and Th17/Treg subset ratios play a significant role in disease outcome and may have potential prognostic value. [76][77][78] However, the presence of EV-A71 neutralizing antibodies was found to be inversely correlated with the number of severe HFMD and the loss of maternal antibodies to be responsible for an increase in severe cases in the 1-2 y age group. 34 The presence of EV-A71 neutralizing antibodies did not reduce the incidence of infections caused by non-A71 enteroviruses.…”
Section: Clinical Presentationmentioning
confidence: 91%
“…The lower prevalence of neutralizing Abs accompanied by higher transmission rates in children and infants indicates that neutralizing Abs are important for the prevention of EV71 infection (8,18). However, 80% of EV71-infected patients become positive for EV71-specific neutralizing Abs 1 d after the onset of illness, and the magnitude of Ab responses are not correlated with disease severity and outcome (19). In contrast, documented clues imply that cellular but not humoral immune responses are correlated with disease progression and clinical outcome (20,21).…”
mentioning
confidence: 99%